

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 6.78637468 |
| 2 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.50412703 |
| 3 | plasma lipoprotein particle assembly (GO:0034377) | 6.16871999 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 6.12565500 |
| 5 | intestinal cholesterol absorption (GO:0030299) | 6.07114120 |
| 6 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.05063012 |
| 7 | protein carboxylation (GO:0018214) | 6.05063012 |
| 8 | lung epithelium development (GO:0060428) | 5.62648920 |
| 9 | protein-lipid complex assembly (GO:0065005) | 5.54691552 |
| 10 | regulation of apoptotic cell clearance (GO:2000425) | 5.39873281 |
| 11 | regulation of cholesterol homeostasis (GO:2000188) | 5.35642691 |
| 12 | chemical homeostasis within a tissue (GO:0048875) | 5.30883238 |
| 13 | low-density lipoprotein particle remodeling (GO:0034374) | 5.26904081 |
| 14 | cholesterol efflux (GO:0033344) | 5.16044481 |
| 15 | proline metabolic process (GO:0006560) | 5.03188888 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 4.93880612 |
| 17 | regulation of fibrinolysis (GO:0051917) | 4.93483312 |
| 18 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.77563651 |
| 19 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72850286 |
| 20 | protein-lipid complex remodeling (GO:0034368) | 4.72850286 |
| 21 | macromolecular complex remodeling (GO:0034367) | 4.72850286 |
| 22 | regulation of complement activation (GO:0030449) | 4.70667058 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.67193123 |
| 24 | positive regulation of synapse maturation (GO:0090129) | 4.66744707 |
| 25 | plasma lipoprotein particle organization (GO:0071827) | 4.63990885 |
| 26 | protein-lipid complex subunit organization (GO:0071825) | 4.39339800 |
| 27 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.26377051 |
| 28 | proline biosynthetic process (GO:0006561) | 4.24113577 |
| 29 | regulation of bile acid biosynthetic process (GO:0070857) | 4.23819604 |
| 30 | regulation of plasminogen activation (GO:0010755) | 4.18814372 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.16965683 |
| 32 | plasma lipoprotein particle clearance (GO:0034381) | 4.12040623 |
| 33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.08633238 |
| 34 | phosphate ion homeostasis (GO:0055062) | 4.00351461 |
| 35 | trivalent inorganic anion homeostasis (GO:0072506) | 4.00351461 |
| 36 | reverse cholesterol transport (GO:0043691) | 3.98955792 |
| 37 | cellular sodium ion homeostasis (GO:0006883) | 3.97735264 |
| 38 | blood coagulation, intrinsic pathway (GO:0007597) | 3.93617837 |
| 39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.80295953 |
| 40 | negative regulation of protein activation cascade (GO:2000258) | 3.75616065 |
| 41 | glutamate metabolic process (GO:0006536) | 3.67541352 |
| 42 | intestinal absorption (GO:0050892) | 3.67479053 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 3.66939988 |
| 44 | negative regulation of sterol transport (GO:0032372) | 3.66939988 |
| 45 | regulation of synapse maturation (GO:0090128) | 3.58569012 |
| 46 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.53967337 |
| 47 | low-density lipoprotein particle clearance (GO:0034383) | 3.51697839 |
| 48 | positive regulation of steroid metabolic process (GO:0045940) | 3.50914607 |
| 49 | cellular anion homeostasis (GO:0030002) | 3.46950665 |
| 50 | positive regulation of hormone metabolic process (GO:0032352) | 3.43648879 |
| 51 | cellular zinc ion homeostasis (GO:0006882) | 3.41896782 |
| 52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.38659852 |
| 53 | negative regulation of complement activation (GO:0045916) | 3.36836881 |
| 54 | positive regulation of extracellular matrix organization (GO:1903055) | 3.34803718 |
| 55 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.33725102 |
| 56 | cholesterol homeostasis (GO:0042632) | 3.31531970 |
| 57 | regulation of cholesterol metabolic process (GO:0090181) | 3.31365037 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.31227322 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 3.31227322 |
| 60 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.29888890 |
| 61 | sterol homeostasis (GO:0055092) | 3.28343539 |
| 62 | diacylglycerol metabolic process (GO:0046339) | 3.27585078 |
| 63 | cell-cell junction maintenance (GO:0045217) | 3.26213539 |
| 64 | sterol transport (GO:0015918) | 3.24984245 |
| 65 | cholesterol transport (GO:0030301) | 3.24984245 |
| 66 | phosphate ion transmembrane transport (GO:0035435) | 3.24602357 |
| 67 | layer formation in cerebral cortex (GO:0021819) | 3.21621133 |
| 68 | central nervous system myelination (GO:0022010) | 3.20708177 |
| 69 | axon ensheathment in central nervous system (GO:0032291) | 3.20708177 |
| 70 | lipoprotein metabolic process (GO:0042157) | 3.19454028 |
| 71 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.18735453 |
| 72 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.18388565 |
| 73 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.17838534 |
| 74 | regulation of extracellular matrix organization (GO:1903053) | 3.17361379 |
| 75 | negative regulation of sodium ion transport (GO:0010766) | 3.14684247 |
| 76 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.13692765 |
| 77 | L-phenylalanine catabolic process (GO:0006559) | 3.13692765 |
| 78 | pinocytosis (GO:0006907) | 3.10686156 |
| 79 | regulation of extracellular matrix disassembly (GO:0010715) | 3.10642607 |
| 80 | protein retention in ER lumen (GO:0006621) | 3.10548050 |
| 81 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.09292821 |
| 82 | sodium ion export (GO:0071436) | 3.08368588 |
| 83 | receptor catabolic process (GO:0032801) | 3.03440210 |
| 84 | nephron tubule morphogenesis (GO:0072078) | 3.01699103 |
| 85 | nephron epithelium morphogenesis (GO:0072088) | 3.01699103 |
| 86 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.00471154 |
| 87 | phospholipid efflux (GO:0033700) | 3.00010559 |
| 88 | positive regulation of phagocytosis (GO:0050766) | 2.99414422 |
| 89 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.96000451 |
| 90 | glutamate secretion (GO:0014047) | 2.95930382 |
| 91 | sodium ion homeostasis (GO:0055078) | 2.93108822 |
| 92 | modified amino acid transport (GO:0072337) | 2.87905053 |
| 93 | drinking behavior (GO:0042756) | 2.87065772 |
| 94 | response to vitamin A (GO:0033189) | 2.81972837 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.79871475 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.79871475 |
| 97 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.77539404 |
| 98 | oligosaccharide catabolic process (GO:0009313) | 2.75996842 |
| 99 | cerebellar granule cell differentiation (GO:0021707) | 2.74162281 |
| 100 | basement membrane organization (GO:0071711) | 2.72723221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.45707458 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.56329841 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.24771457 |
| 4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.16712296 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00658693 |
| 6 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.74709690 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.72448438 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.60876758 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53649148 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46687490 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.25472872 |
| 12 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.23257596 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.21792305 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.21617765 |
| 15 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.20895269 |
| 16 | KDM2B_26808549_Chip-Seq_K562_Human | 2.04866499 |
| 17 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.04254607 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98822371 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.98481391 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.96458048 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.94083222 |
| 22 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.91392393 |
| 23 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.88773883 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85370768 |
| 25 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.82015425 |
| 26 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.77645068 |
| 27 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.77337419 |
| 28 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.71878875 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70858933 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67780905 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.63246507 |
| 32 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.62459998 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60550982 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59956532 |
| 35 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58754182 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.57906171 |
| 37 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.57243622 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.53650519 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52909426 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51967685 |
| 41 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45373469 |
| 42 | P68_20966046_ChIP-Seq_HELA_Human | 1.45163770 |
| 43 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.44060696 |
| 44 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.40538346 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39900193 |
| 46 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.39744190 |
| 47 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38968908 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38499342 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33199377 |
| 50 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32257907 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32095949 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.30420807 |
| 53 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30391806 |
| 54 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29534671 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27322791 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25069039 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24410205 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22747699 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21303066 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.19928495 |
| 61 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.16304179 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15960149 |
| 63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14594272 |
| 64 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14526067 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14059879 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14028323 |
| 67 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13682746 |
| 68 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13180004 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13064529 |
| 70 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12449849 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11915735 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10436691 |
| 73 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.10394831 |
| 74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08578166 |
| 75 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07334105 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07019812 |
| 77 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06926835 |
| 78 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.06029658 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05722015 |
| 80 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.05556619 |
| 81 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05006858 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04952305 |
| 83 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04823692 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02496340 |
| 85 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01477982 |
| 86 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01042580 |
| 87 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00433982 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99818697 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99806767 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99175347 |
| 91 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98634798 |
| 92 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97178408 |
| 93 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95369881 |
| 94 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.93944336 |
| 95 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93452469 |
| 96 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.92045132 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91804740 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91245450 |
| 99 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.90965629 |
| 100 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90427963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.72778012 |
| 2 | MP0003122_maternal_imprinting | 5.29473536 |
| 3 | MP0000566_synostosis | 4.48434816 |
| 4 | MP0003123_paternal_imprinting | 3.86463899 |
| 5 | MP0004782_abnormal_surfactant_physiolog | 3.33517323 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.21292743 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 2.99149332 |
| 8 | MP0005365_abnormal_bile_salt | 2.95124904 |
| 9 | MP0002089_abnormal_postnatal_growth/wei | 2.90989036 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.76831917 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.59386777 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.49851746 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.44934639 |
| 14 | MP0004270_analgesia | 2.30498379 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.13386664 |
| 16 | MP0003195_calcinosis | 2.07949324 |
| 17 | MP0005451_abnormal_body_composition | 2.01558847 |
| 18 | MP0003879_abnormal_hair_cell | 1.98994528 |
| 19 | MP0005409_darkened_coat_color | 1.89605467 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 1.82276008 |
| 21 | MP0003329_amyloid_beta_deposits | 1.81935604 |
| 22 | MP0001958_emphysema | 1.79602425 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 1.66351473 |
| 24 | MP0008260_abnormal_autophagy | 1.65743164 |
| 25 | MP0000678_abnormal_parathyroid_gland | 1.65165944 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.63374262 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.59352254 |
| 28 | MP0001915_intracranial_hemorrhage | 1.48775852 |
| 29 | MP0009840_abnormal_foam_cell | 1.47386701 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.47233892 |
| 31 | MP0003115_abnormal_respiratory_system | 1.45774804 |
| 32 | MP0008569_lethality_at_weaning | 1.40698133 |
| 33 | MP0003121_genomic_imprinting | 1.36834799 |
| 34 | MP0000639_abnormal_adrenal_gland | 1.36568195 |
| 35 | MP0000920_abnormal_myelination | 1.34817353 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.32199562 |
| 37 | MP0009046_muscle_twitch | 1.30800911 |
| 38 | MP0002249_abnormal_larynx_morphology | 1.29806104 |
| 39 | MP0002064_seizures | 1.29017509 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.22963118 |
| 41 | MP0001348_abnormal_lacrimal_gland | 1.18371088 |
| 42 | MP0003942_abnormal_urinary_system | 1.18290327 |
| 43 | MP0001177_atelectasis | 1.14383013 |
| 44 | MP0003690_abnormal_glial_cell | 1.13135311 |
| 45 | MP0005332_abnormal_amino_acid | 1.11965142 |
| 46 | MP0003252_abnormal_bile_duct | 1.10699342 |
| 47 | MP0000604_amyloidosis | 1.08551712 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.07272005 |
| 49 | MP0003635_abnormal_synaptic_transmissio | 1.06999785 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.05824093 |
| 51 | MP0000609_abnormal_liver_physiology | 1.05347626 |
| 52 | MP0003878_abnormal_ear_physiology | 0.99077186 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 0.99077186 |
| 54 | MP0005083_abnormal_biliary_tract | 0.98821237 |
| 55 | MP0004272_abnormal_basement_membrane | 0.97657349 |
| 56 | MP0003632_abnormal_nervous_system | 0.97108003 |
| 57 | MP0008995_early_reproductive_senescence | 0.95843643 |
| 58 | MP0005257_abnormal_intraocular_pressure | 0.94117526 |
| 59 | MP0000681_abnormal_thyroid_gland | 0.90982325 |
| 60 | MP0005410_abnormal_fertilization | 0.90586786 |
| 61 | MP0003880_abnormal_central_pattern | 0.89095305 |
| 62 | MP0005408_hypopigmentation | 0.87687099 |
| 63 | MP0004742_abnormal_vestibular_system | 0.82763811 |
| 64 | MP0001849_ear_inflammation | 0.82391248 |
| 65 | MP0002063_abnormal_learning/memory/cond | 0.81894032 |
| 66 | MP0004858_abnormal_nervous_system | 0.81559406 |
| 67 | MP0003631_nervous_system_phenotype | 0.81437143 |
| 68 | MP0001486_abnormal_startle_reflex | 0.80371873 |
| 69 | MP0001270_distended_abdomen | 0.77544915 |
| 70 | MP0001661_extended_life_span | 0.74742477 |
| 71 | MP0003634_abnormal_glial_cell | 0.74484366 |
| 72 | MP0002557_abnormal_social/conspecific_i | 0.73886048 |
| 73 | MP0003315_abnormal_perineum_morphology | 0.73726192 |
| 74 | MP0000534_abnormal_ureter_morphology | 0.73647012 |
| 75 | MP0003633_abnormal_nervous_system | 0.72772857 |
| 76 | MP0001440_abnormal_grooming_behavior | 0.72293353 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.70430903 |
| 78 | MP0001346_abnormal_lacrimal_gland | 0.67728622 |
| 79 | MP0009672_abnormal_birth_weight | 0.67011745 |
| 80 | MP0005388_respiratory_system_phenotype | 0.66093842 |
| 81 | MP0002133_abnormal_respiratory_system | 0.66093842 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.65862261 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.64230658 |
| 84 | MP0003868_abnormal_feces_composition | 0.63728132 |
| 85 | MP0002229_neurodegeneration | 0.62836219 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.61905166 |
| 87 | MP0003075_altered_response_to | 0.61669231 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 0.60841594 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.60450784 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.60288525 |
| 91 | MP0002184_abnormal_innervation | 0.59833970 |
| 92 | MP0000598_abnormal_liver_morphology | 0.59362868 |
| 93 | MP0000955_abnormal_spinal_cord | 0.58798346 |
| 94 | MP0005646_abnormal_pituitary_gland | 0.57844178 |
| 95 | MP0002272_abnormal_nervous_system | 0.55999663 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.54899703 |
| 97 | MP0010234_abnormal_vibrissa_follicle | 0.54829610 |
| 98 | MP0002132_abnormal_respiratory_system | 0.54459319 |
| 99 | MP0001730_embryonic_growth_arrest | 0.54209525 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.54080011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.07257443 |
| 2 | Joint hemorrhage (HP:0005261) | 5.74812837 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 4.89201884 |
| 4 | Hemorrhage of the eye (HP:0011885) | 4.21972810 |
| 5 | Complement deficiency (HP:0004431) | 4.06422853 |
| 6 | Hypercholesterolemia (HP:0003124) | 4.05931562 |
| 7 | Xanthomatosis (HP:0000991) | 4.00404287 |
| 8 | Glomerulonephritis (HP:0000099) | 3.71925330 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.58069237 |
| 10 | Interstitial pulmonary disease (HP:0006530) | 3.48976581 |
| 11 | Small epiphyses (HP:0010585) | 3.41081220 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.35106597 |
| 13 | Menorrhagia (HP:0000132) | 3.23308528 |
| 14 | Abnormality of complement system (HP:0005339) | 3.17728302 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.17170230 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.14624862 |
| 17 | Cerebral aneurysm (HP:0004944) | 3.11780456 |
| 18 | Asymmetry of the thorax (HP:0001555) | 3.07175715 |
| 19 | Broad alveolar ridges (HP:0000187) | 2.88330969 |
| 20 | Bronchomalacia (HP:0002780) | 2.79658958 |
| 21 | Neurofibrillary tangles (HP:0002185) | 2.79186453 |
| 22 | Purpura (HP:0000979) | 2.76743856 |
| 23 | Abnormality of carpal bone ossification (HP:0006257) | 2.64612207 |
| 24 | Epiphyseal dysplasia (HP:0002656) | 2.59037963 |
| 25 | Alacrima (HP:0000522) | 2.57478234 |
| 26 | Abnormality of the lumbar spine (HP:0100712) | 2.56293862 |
| 27 | Vaginal fistula (HP:0004320) | 2.53994260 |
| 28 | Hypolipoproteinemia (HP:0010981) | 2.53873365 |
| 29 | Vascular calcification (HP:0004934) | 2.44335338 |
| 30 | Broad palm (HP:0001169) | 2.43166995 |
| 31 | Mitral stenosis (HP:0001718) | 2.31442769 |
| 32 | Gout (HP:0001997) | 2.29568755 |
| 33 | Impaired pain sensation (HP:0007328) | 2.29105929 |
| 34 | Abnormality of pain sensation (HP:0010832) | 2.29105929 |
| 35 | Protrusio acetabuli (HP:0003179) | 2.26752665 |
| 36 | Acanthocytosis (HP:0001927) | 2.26629595 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 2.26474464 |
| 38 | Cerebral inclusion bodies (HP:0100314) | 2.25503531 |
| 39 | Renal duplication (HP:0000075) | 2.24522225 |
| 40 | Aplasia involving bones of the extremities (HP:0009825) | 2.21205079 |
| 41 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.21205079 |
| 42 | Aplasia of the phalanges of the hand (HP:0009802) | 2.21205079 |
| 43 | Flat acetabular roof (HP:0003180) | 2.21199334 |
| 44 | Myocardial infarction (HP:0001658) | 2.21159085 |
| 45 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.20149653 |
| 46 | Skin nodule (HP:0200036) | 2.16375610 |
| 47 | Irregular epiphyses (HP:0010582) | 2.14763217 |
| 48 | Bifid scrotum (HP:0000048) | 2.12001476 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.07174720 |
| 50 | Epidermoid cyst (HP:0200040) | 2.07070145 |
| 51 | Scanning speech (HP:0002168) | 2.06971241 |
| 52 | Abnormal ossification of hand bones (HP:0005921) | 2.05668926 |
| 53 | Limited elbow extension (HP:0001377) | 2.05464763 |
| 54 | Hypoalphalipoproteinemia (HP:0003233) | 2.05060273 |
| 55 | Growth hormone excess (HP:0000845) | 2.04554824 |
| 56 | Epileptic encephalopathy (HP:0200134) | 2.04266196 |
| 57 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.03048409 |
| 58 | Neonatal death (HP:0003811) | 2.02819465 |
| 59 | Spontaneous abortion (HP:0005268) | 2.01158913 |
| 60 | Hepatoblastoma (HP:0002884) | 1.98711508 |
| 61 | Abnormal tarsal ossification (HP:0008369) | 1.91416606 |
| 62 | Abnormality of the Achilles tendon (HP:0005109) | 1.90554985 |
| 63 | Ulnar bowing (HP:0003031) | 1.89567204 |
| 64 | Wide nose (HP:0000445) | 1.88525916 |
| 65 | Insomnia (HP:0100785) | 1.88069008 |
| 66 | Abnormal hand bone ossification (HP:0010660) | 1.86741765 |
| 67 | Annular pancreas (HP:0001734) | 1.85701417 |
| 68 | Absent epiphyses (HP:0010577) | 1.85302493 |
| 69 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.85302493 |
| 70 | Arnold-Chiari malformation (HP:0002308) | 1.82860806 |
| 71 | Abnormality of the lacrimal duct (HP:0011481) | 1.82343794 |
| 72 | Nasolacrimal duct obstruction (HP:0000579) | 1.81425508 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 1.81174838 |
| 74 | Cholecystitis (HP:0001082) | 1.81174838 |
| 75 | Status epilepticus (HP:0002133) | 1.81053859 |
| 76 | Flared iliac wings (HP:0002869) | 1.78836281 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76427394 |
| 78 | Mucopolysacchariduria (HP:0008155) | 1.76427394 |
| 79 | Facial shape deformation (HP:0011334) | 1.75608648 |
| 80 | Potter facies (HP:0002009) | 1.75608648 |
| 81 | Hypophosphatemic rickets (HP:0004912) | 1.74948495 |
| 82 | Choanal stenosis (HP:0000452) | 1.73922845 |
| 83 | Menstrual irregularities (HP:0000858) | 1.73351021 |
| 84 | Decreased lacrimation (HP:0000633) | 1.72918270 |
| 85 | Akinesia (HP:0002304) | 1.71841533 |
| 86 | Biconcave vertebral bodies (HP:0004586) | 1.71321743 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 1.70152299 |
| 88 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.69289683 |
| 89 | Abnormality of the nasal septum (HP:0000419) | 1.69081413 |
| 90 | Heterotopia (HP:0002282) | 1.68665910 |
| 91 | Atonic seizures (HP:0010819) | 1.67812024 |
| 92 | Hyperacusis (HP:0010780) | 1.67603637 |
| 93 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.66625460 |
| 94 | Supernumerary ribs (HP:0005815) | 1.66120068 |
| 95 | Gonadal dysgenesis (HP:0000133) | 1.64298265 |
| 96 | Hypotension (HP:0002615) | 1.61609673 |
| 97 | Widely patent fontanelles and sutures (HP:0004492) | 1.61539089 |
| 98 | Renovascular hypertension (HP:0100817) | 1.61475880 |
| 99 | Abnormality of the vitreous humor (HP:0004327) | 1.60536257 |
| 100 | Action tremor (HP:0002345) | 1.60111615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 6.24368927 |
| 2 | ICK | 3.65441930 |
| 3 | FGFR3 | 3.46385919 |
| 4 | RIPK1 | 3.39684947 |
| 5 | TRIB3 | 3.25612481 |
| 6 | WNK4 | 2.59908385 |
| 7 | TYRO3 | 2.51723541 |
| 8 | EEF2K | 2.47478009 |
| 9 | CDK12 | 2.32219558 |
| 10 | EPHA2 | 2.27819223 |
| 11 | NTRK3 | 2.15953925 |
| 12 | ERN1 | 1.91630007 |
| 13 | LATS2 | 1.90374123 |
| 14 | WNK1 | 1.87710173 |
| 15 | SIK1 | 1.87654676 |
| 16 | PDGFRA | 1.87287355 |
| 17 | FGFR2 | 1.84016434 |
| 18 | SMG1 | 1.83691758 |
| 19 | MST1R | 1.76864212 |
| 20 | MAP3K9 | 1.71332645 |
| 21 | EPHA4 | 1.63720254 |
| 22 | PKN2 | 1.55657279 |
| 23 | FGFR1 | 1.54874955 |
| 24 | DAPK2 | 1.50432652 |
| 25 | PDPK1 | 1.43184534 |
| 26 | NTRK2 | 1.38836711 |
| 27 | DYRK1B | 1.38442406 |
| 28 | SIK2 | 1.38297319 |
| 29 | MARK2 | 1.22393859 |
| 30 | RET | 1.13050826 |
| 31 | KSR2 | 1.12903300 |
| 32 | UHMK1 | 1.11923245 |
| 33 | CAMKK1 | 1.11761674 |
| 34 | DDR2 | 1.11197241 |
| 35 | PRKD3 | 1.10065580 |
| 36 | SGK223 | 1.05299258 |
| 37 | SGK494 | 1.05299258 |
| 38 | PDK1 | 0.94752964 |
| 39 | PRPF4B | 0.94302662 |
| 40 | NTRK1 | 0.91621802 |
| 41 | MAPK11 | 0.90455566 |
| 42 | LATS1 | 0.89863623 |
| 43 | BRSK1 | 0.86998084 |
| 44 | CDC42BPA | 0.86871573 |
| 45 | MAP3K2 | 0.82496742 |
| 46 | IRAK3 | 0.81731798 |
| 47 | STK38 | 0.78865283 |
| 48 | SGK3 | 0.78545863 |
| 49 | PAK6 | 0.77884174 |
| 50 | MET | 0.77706162 |
| 51 | AKT3 | 0.74793206 |
| 52 | MAP3K1 | 0.74428754 |
| 53 | MTOR | 0.69355128 |
| 54 | MAPKAPK3 | 0.68518852 |
| 55 | ALK | 0.68377676 |
| 56 | MAP3K13 | 0.67301817 |
| 57 | MINK1 | 0.66900365 |
| 58 | LMTK2 | 0.65385076 |
| 59 | ERBB2 | 0.64730427 |
| 60 | PTK2 | 0.63896567 |
| 61 | DAPK1 | 0.62819658 |
| 62 | RPS6KB1 | 0.60201733 |
| 63 | SGK1 | 0.58888824 |
| 64 | MAP3K7 | 0.57726796 |
| 65 | PTK6 | 0.57119456 |
| 66 | CDK15 | 0.55919837 |
| 67 | MAP2K6 | 0.53843423 |
| 68 | NEK6 | 0.53093242 |
| 69 | MAP3K11 | 0.52828928 |
| 70 | PRKAA2 | 0.49547461 |
| 71 | SGK2 | 0.49386199 |
| 72 | ARAF | 0.49333326 |
| 73 | CDK18 | 0.49110630 |
| 74 | CDK7 | 0.48460863 |
| 75 | CAMK1D | 0.48448884 |
| 76 | CDK11A | 0.48366514 |
| 77 | PIK3CA | 0.46196269 |
| 78 | NME1 | 0.46071411 |
| 79 | CAMK4 | 0.45963312 |
| 80 | MAPK10 | 0.45655796 |
| 81 | CDK5 | 0.45109405 |
| 82 | FGR | 0.43817540 |
| 83 | PAK4 | 0.43066060 |
| 84 | BMX | 0.40059323 |
| 85 | MAP2K3 | 0.39747741 |
| 86 | CSNK1E | 0.38350821 |
| 87 | PRKAA1 | 0.37875756 |
| 88 | CDK14 | 0.37761091 |
| 89 | RPS6KA2 | 0.34933400 |
| 90 | SRC | 0.33612557 |
| 91 | MAPK12 | 0.32446588 |
| 92 | RPS6KA3 | 0.31780472 |
| 93 | PDGFRB | 0.29667379 |
| 94 | HIPK2 | 0.28374874 |
| 95 | MAPK8 | 0.26893104 |
| 96 | RPS6KB2 | 0.25995594 |
| 97 | MARK1 | 0.25778277 |
| 98 | TGFBR2 | 0.25306302 |
| 99 | CDK6 | 0.24498298 |
| 100 | PRKG2 | 0.24371778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.29597832 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.48354038 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.85905833 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.84215253 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43217056 |
| 6 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.29241363 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.28388075 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.19603075 |
| 9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.14831457 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.98774641 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.95789015 |
| 12 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.91492800 |
| 13 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.86610367 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.83916918 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83804351 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76628981 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.70642614 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 1.61418678 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61061711 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54667111 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50118554 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47069536 |
| 23 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.45308069 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.37364137 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.35793861 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33624995 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.23318642 |
| 28 | Prion diseases_Homo sapiens_hsa05020 | 1.21854225 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.20369461 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18819544 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.13698692 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12326537 |
| 33 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10121838 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05570576 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02685124 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99170228 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98327209 |
| 38 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97976441 |
| 39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97222193 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95064320 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92686057 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85293389 |
| 43 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83763419 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83399000 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83372581 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83298959 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82085216 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80927938 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.80868087 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.80785952 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78918299 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77458247 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.77269048 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76441891 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.75170616 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72795583 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71902475 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70916863 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.70081538 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70074031 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 0.69193397 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69165149 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67938450 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67889592 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65299679 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65090358 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64713272 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.63582483 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63564733 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61642551 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61197583 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60630883 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59226132 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58822045 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56550117 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54805070 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53738381 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.53704367 |
| 79 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52970746 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51561307 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48346812 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.48270644 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47680928 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46405069 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45840692 |
| 86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45601206 |
| 87 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43808819 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43730228 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.42920496 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39154985 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37636965 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.37228520 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37018850 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36603812 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35103897 |
| 96 | Insulin secretion_Homo sapiens_hsa04911 | 0.33427103 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.32980932 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31992208 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.31423229 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30784728 |

